Share Email Print
cover

Proceedings Paper

Effects of laser immunotherapy on late-stage, metastatic breast cancer patients in a Phase II clinical trial
Author(s): Gabriela L. Ferrel; Feifan Zhou; Xiaosong Li; Tomas Hode; Robert E. Nordquist; Luciano Alleruzzo; Wei R. Chen
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Laser immunotherapy (LIT), a novel technique with a local intervention to induce systemic antitumor effects, was developed to treat metastatic cancers. The pre-clinical studies of LIT have shown its unique characteristics in generating a specific antitumor immunity in treating metastatic tumors in rats and mice. For late-stage, metastatic breast cancer patients, who were considered to be out of other available treatment options, we conducted a small Phase II clinical trial using LIT starting in 2009 in Lima, Peru. This Phase II study was closed in December of 2012, as acknowldged by the Ministry of Health (MOH) of Peur letter 438-2014-OGITT/INS dated March 5th, 2014. Ten patients were enrolled and received LIT in one or multiple 4-week treatment cycles. At the study closing date, four patients were alive and two of them remained cancer free. Here, following the successful conclusion of our Phase II study, we report the clinical effects of LIT on metastatic breast cancer patients. Specifically, we present the overall status of all the patients three years after the treatment and also the outcomes of two long-term surviving patients.

Paper Details

Date Published: 13 March 2014
PDF: 9 pages
Proc. SPIE 8944, Biophotonics and Immune Responses IX, 89440I (13 March 2014); doi: 10.1117/12.2041263
Show Author Affiliations
Gabriela L. Ferrel, Hospital Nacional Edgardo Rebagliati Martins (Peru)
Feifan Zhou, Univ. of Central Oklahoma (United States)
Xiaosong Li, Chinese PLA General Hospital (China)
Tomas Hode, Immunophotonics, Inc. (United States)
Robert E. Nordquist, Immunophotonics, Inc. (United States)
Luciano Alleruzzo, Immunophotonics, Inc. (United States)
Wei R. Chen, Univ. of Central Oklahoma (United States)


Published in SPIE Proceedings Vol. 8944:
Biophotonics and Immune Responses IX
Wei R. Chen, Editor(s)

© SPIE. Terms of Use
Back to Top